Global Immuno-oncology Drugs Market Size growing at a CAGR of 14.2% during 2018-2025

Albany, US, July 5, 2018: An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Immuno-oncology Drugs Market” Research Report 2018 which provides an outlook for current market value as well as the expected growth of Immuno-oncology Drugs Market during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export in these regions.

Click Here to Get the Sample Copy of the Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1848224

This report studies the global Immuno-oncology Drugs market status and forecast, categorizes the global Immuno-oncology Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Immuno-oncology Drugs market is valued at 49200 million US$ in 2017 and will reach 142200 million US$ by the end of 2025, growing at a CAGR of 14.2% during 2018-2025.

The major manufacturers covered in this report
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Pharmacies
Online Pharmacies

 View Full Report with Table and Content@ https://www.marketresearchhub.com/report/global-immuno-oncology-drugs-market-research-report-2018-report.html

Table of Contents

Global Immuno-oncology Drugs Market Research Report 2018
1 Immuno-oncology Drugs Market Overview
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Immuno-oncology Drugs Segment by Type (Product Category)
1.2.1 Global Immuno-oncology Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Immuno-oncology Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine-Based Immunotherapy
1.2.6 Cancer Vaccines
1.2.7 CAR-T Cell Therapy
1.3 Global Immuno-oncology Drugs Segment by Application
1.3.1 Immuno-oncology Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Global Immuno-oncology Drugs Market by Region (2013-2025)
1.4.1 Global Immuno-oncology Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Immuno-oncology Drugs (2013-2025)
1.5.1 Global Immuno-oncology Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Immuno-oncology Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Immuno-oncology Drugs Market Competition by Manufacturers
2.1 Global Immuno-oncology Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Immuno-oncology Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Immuno-oncology Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Immuno-oncology Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Immuno-oncology Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Immuno-oncology Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Immuno-oncology Drugs Market Competitive Situation and Trends
2.5.1 Immuno-oncology Drugs Market Concentration Rate
2.5.2 Immuno-oncology Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Immuno-oncology Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Immuno-oncology Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Immuno-oncology Drugs Production and Market Share by Region (2013-2018)
3.3 Global Immuno-oncology Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Immuno-oncology Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

Continued….. @@

 Enquire Full Details about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1848224

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical market research   and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

Website: http://www.marketresearchhub.com/

Read Industry News at: https://www.industrynewsanalysis.com/

Matched content

Editor’s pick

Express Press Release Distribution